SERENITY BIOWORKS
Serenity is a therapeutics company focusing on cellular stress pathways. We've acquired a clinical-stage stress therapeutic, previously known as DC-TAB, based on promising data in MS patients. Based on Serenity's internal efforts, it was discovered that this drug could confer benefit for lupus nephritis, a devastating kidney disorder that afflicts lupus patients. Serenity is now advancing their lead drug under the name SER-101 for lupus nephritis.
SERENITY BIOWORKS
Industry:
Biotechnology Health Care Therapeutics
Founded:
2017-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.serenitybioworks.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
2.03 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Euro GStatic Google Static Content Wix Wix Forms
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Current Employees Featured
Founder
Investors List
SOSV
SOSV investment in Convertible Note - Serenity Bioworks
IndieBio
IndieBio investment in Convertible Note - Serenity Bioworks
IndieBio
IndieBio investment in Seed Round - Serenity Bioworks
SOSV
SOSV investment in Seed Round - Serenity Bioworks
Velocity
Velocity investment in Grant - Serenity Bioworks
Official Site Inspections
http://www.serenitybioworks.com Semrush global rank: 5.33 M Semrush visits lastest month: 1.56 K
- Host name: 172.67.173.3
- IP address: 172.67.173.3
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Serenity Bioworks"
Serenity Bioworks - Crunchbase Company Profile & Funding
Serenity is developing antibody mimetics for targeted protein degradation. The company's innovative approaches combine advanced display techniques with in silico predictions, …See details»
SERENITY BIOWORKS INC. | Canada Corporation Directory
SERENITY BIOWORKS INC. is a Non-distributing corporation with 50 or fewer shareholders corporation type, which located at 1406 Laburnum St Vancouver BC V6J 3W3 Canada.See details»
Serenity Bioworks Company Profile | Management and Employees …
Www.serenitybioworks.com . Serenity Bioworks Profile and History. Serenity is improving the production and performance of protein-based therapeutics. Serenity Bioworks has large plans …See details»
Serenity Bioworks - LinkedIn
Serenity Bioworks is focused on developing protein-based therapeutics that push the frontier and make a big difference for patients.See details»
Serenity Bioworks - Craft
Serenity Bioworks has 5 employees across 2 locations and $18.93 k in total funding,. See insights on Serenity Bioworks including office locations, competitors, revenue, financials, executives, …See details»
Serenity Bioworks - Overview, News & Similar companies - ZoomInfo
Apr 26, 2022 Serenity Bioworks contact info: Phone number: (416) 356-3253 Website: www.serenitybioworks.com What does Serenity Bioworks do? Serenity is improving the …See details»
Serenity Bioworks, Inc. - Drug pipelines, Patents, Clinical trials ...
Www.serenitybioworks.com. Last update 11 Jul 2024See details»
Serenity Bioworks - VentureRadar
Website: http://www.serenitybioworks.com. Develops a unique drug discovery platform, StressTek, focusing on endogenous stress pathways to identify key tolerance ...See details»
Serenity Bioworks' Leadership Team - Team members and org …
About. The leadership team at Serenity Bioworks has a long history of experience in the scientific community. Many of the team members have worked as research scientists at various …See details»
Serenity Bioworks - Org Chart, Teams, Culture & Jobs | The Org
View Serenity Bioworks' up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Serenity Bioworks - PitchBook
Serenity Bioworks General Information Description. Developer of gene therapies designed to address underserved areas in healthcare and improve patient outcomes. The company's …See details»
Serenity Bioworks - Products, Competitors, Financials, Employees ...
Serenity Bioworks wins $35,000 from Velocity Fund Finals. Apr 5, 2017. The University of Waterloo hosted their 18th annual Velocity Fund Finals, where 20 companies pitched for a …See details»
Serenity Bioworks - Golden
Serenity Bioworks is an immune-compatible gene therapy company founded in 2017 by Cody Shirriff.See details»
Spencer Berg - COO at Serenity Bioworks - The Org
Spencer Berg is currently the COO at Serenity Bioworks.Prior to that, they were a technologist at Labstat International ULC from September 2016 to April 2017. Before that, they were a …See details»
Serenity Bioworks (DC-Tab) - PitchBook
Information on acquisition, funding, investors, and executives for Serenity Bioworks (DC-Tab). Use the PitchBook Platform to explore the full profile.See details»
Serenity Bioworks | CipherBio
Explore Serenity Bioworks's investment information, scientific platforms, therapeutic approaches, indications and more here!See details»
Serenity Bioworks - Company Information, Competitors, News
Find useful insights on Serenity Bioworks's company details, tech stack, news alerts, competitors and more. Use 6sense to connect with top decision-makers at Serenity Bioworks.See details»
Serenity Bioworks - IndieBio - #1 in Early Stage Biotech
Serenity is a therapeitucs company focusing on cellular stress pathways. Their premise is that when cells encounter a stressful environment — whether it be a lack of oxygen, increase in …See details»
Serenity Bioworks Asset Profile | Preqin
Founded in 2017 and based in California, US, Serenity Bioworks operates Cargotek, a platform that improves the production and performance of protein-based th...See details»
Serenity Bio’s acquisition of DC-TAB | by Cody Shirriff - Medium
Apr 27, 2022 Summary of risk. In a blog post by the successful biotech entrepreneur Michael Gilman, he distilled the risk of an early-stage program into 3 core hypotheses: biological, …See details»